semaglutide a1c reduction 50 mg of oral #semaglutide daily was associated with body weight and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Is Weight Loss the Main

Retatrutide (development code LY3437943 ) is a single synthetic peptide developed by Eli Lilly that acts as a triple agonist at three receptors simultaneously: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor

Improve the integrity of the skin barrier and water-holding protein density to prevent moisture loss and retain water more efficiently Get your glow on

Increase to 0.75mg (0.15mL) for three additional trials before moving to 1.0mg (0.2mL)

Practice Relaxation: Engage in deep breathing exercises or meditation to reduce anxiety-related chest discomfort